Abbott
Trade Abbott 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABT
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
ABT Key Statistics
Stock Snapshot
As of today, Abbott(ABT) shares are valued at $108.22. The company's market cap stands at 200.56B, with a P/E ratio of 31.94 and a dividend yield of 2.47%.
During the trading session on 2026-07-30, Abbott(ABT) shares reached a daily high of $110.03 and a low of $106.97. At a current price of $108.22, the stock is +1.2% higher than the low and still -1.6% under the high.
Trading activity shows a volume of 12.16M, compared to an average daily volume of 14.57M.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.
Over the past 52 weeks, Abbott(ABT) stock has traded between a high of $137.49 and a low of $81.97.
ABT News
FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to c...
In a report released yesterday, Josh Jennings from TD Cowen maintained a Buy rating on Abbott Laboratories, with a price target of $115.00. Claim 55% Off TipRan...
The 2026 Q2 earnings cycle continues to roll along, with the reporting docket remaining stacked in the coming days and weeks. The period has been another one of...
Analyst ratings
78%
of 27 ratingsMore ABT News
Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in adults 45 and...
Schwab US Dividend Equity ETF ( $SCHD ) has risen by 1.65% in the past week. It has experienced a 5-day net inflow of $682.61 million. This is due, in part, to...
Abbott Laboratories (ABT) is back on investors’ radar after second quarter 2026 earnings showed higher year over year sales alongside lower net income and earni...
Social Security reform is back in the headlines, and the bipartisan PROMISE Act has put retirement income security under a brighter spotlight. With projections...
In its recently reported second-quarter 2026 results, Abbott Laboratories posted sales of US$12,593 million, up from US$11,142 million a year earlier, while net...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.